Allworth Financial LP - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allworth Financial LP ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,089
+14.0%
511
+24.3%
0.00%
Q2 2023$12,355
+287.4%
411
+367.0%
0.00%
Q1 2023$3,189
+49.0%
88
+46.7%
0.00%
Q4 2022$2,140
+114.0%
60
+50.0%
0.00%
Q3 2022$1,0000.0%400.0%0.00%
Q2 2022$1,0000.0%400.0%0.00%
Q1 2022$1,0000.0%400.0%0.00%
Q4 2021$1,0000.0%400.0%0.00%
Q3 2021$1,0000.0%400.0%0.00%
Q2 2021$1,0000.0%400.0%0.00%
Q1 2021$1,0000.0%400.0%0.00%
Q4 2020$1,0000.0%400.0%0.00%
Q3 2020$1,0000.0%400.0%0.00%
Q2 2020$1,0000.0%40
-2.4%
0.00%
Q1 2020$1,0000.0%410.0%0.00%
Q4 2019$1,0000.0%410.0%0.00%
Q3 2019$1,0000.0%410.0%0.00%
Q2 2019$1,0000.0%410.0%0.00%
Q1 2019$1,0000.0%41
+2.5%
0.00%
Q4 2018$1,000
-50.0%
400.0%0.00%
Q3 2018$2,0000.0%400.0%0.00%
Q2 2018$2,0000.0%400.0%0.00%
Q1 2018$2,000400.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
HealthInvest Partners AB 335,000$8,934,00013.38%
ASHFORD CAPITAL MANAGEMENT INC 1,016,665$27,114,0002.46%
Bruce & Co., Inc. 402,105$10,724,0002.28%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 297,500$7,934,0001.91%
ARMISTICE CAPITAL, LLC 3,900,000$104,013,0001.76%
Bridge City Capital, LLC 108,884$2,904,0001.32%
S&T BANK/PA 316,098$8,430,0001.31%
Kent Lake Capital LLC 100,000$2,667,0001.15%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 331,140$8,832,0001.02%
Prairiewood Capital, LLC 45,297$1,208,0000.99%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders